Who Is Eligible for Targeted and Immune Therapies?
Justin F. Gainor, M.D., explains who is eligible for targeted and immune therapies in this clip from our expert panel discussion on tumor testing. For more information and to see the full recorded discussion, visit Lung.org/tumor-testing-videos.
Generously supported by AstraZeneca, Bristol-Myers Squibb, Foundation Medicine, Pfizer, and Merck & Co., Inc.
Who is eligible for targeted and immune therapies?
When we’re thinking about using targeted therapies, when we’re thinking about using immune therapies, these are usually in the context of people who have metastatic cancer, or stage 4 disease. That means the cancer has spread outside of the lung. For cancers that are earlier or contained within the lung, our primary therapies are things like surgery and radiation. But when cancers escape outside of the lung, we generally rely on drug therapies. So that’s really where these genetic tests and this PD-L1 test is most important, in that setting.
Page Last Updated: November 9, 2018
Sign up for the latest lung health news sent right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.